期刊文献+

CD44V_3、CD44V_6基因蛋白在卵巢恶性肿瘤中的表达及临床意义 被引量:4

Expression of CD44V 3,CD44V 6 and Its Clinical Significance in Malignant Ovarian Rumor
下载PDF
导出
摘要 目的 探讨恶性卵巢肿瘤组织中CD44V3 、CD44V6 的表达及其临床意义。方法 用免疫组织化学方法,检测41 例卵巢恶性肿瘤、20 例卵巢良性肿瘤和21 例正常卵巢组织中CD44V3 、CD44V6 基因蛋白的表达情况并分析相关的临床病理因素。结果 CD44V3 、CD44V6 表达阳性率恶性组显著高于良性组和正常组;有转移者CD44V3 、CD44V6 阳性率显著高于无转移者,转移灶阳性率高于原发灶;CD44V3 、CD44V6 阳性表达者近期疗效比阴性者差;CD44V3 、CD44V6 阳性表达率与病理类型、组织学级别无关。结论 CD44V3 、CD44V6 与近期疗效有关,可作为评估预后的指标。 Objective To detect the expression of CD44V 3,CD44V 6 in ovarian carcinoma and to investigate its clinical significance in malignant ovarian tumor.Methods The immunohistochemical stain was used to detect the expression proteins of CD44V 3,CD44V 6 in biopsy samples of 41 malignant ovarian tumors,20 benign ovarian tumors and 21 normal controls.Results (1) the positive expression rates of CD44V 3,CD44V 6 protein in malignance were significantly higher than that in benign and control; (2) The positive expression rates of CD44V 3,CD44V 6 in residual foci which >2cm were signiicantly higher than that residual foci which were≤2cm.(3) The positive expression rates of CD44V 3,CD44V 6 in metastatic focus were significantly higher than that in primary focus;the positive expression rates in the pirmary focus with metastasis were significantly higher than that without metastasis.(4) The short term curative effects of patient with positive expression of CD44V 3,CD44V 6 were significantly lower than that of negative patients with such expression.(5) No significant correlation was observed between the positive expression rate of CD44 and pathological type,or histological grade in cancer tissue,Conclusion The over expression of CD44V 3,CD44V 6 was correlated with the curative effects,it would be a new marker for evaluating the curative effects and prognosis.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 1999年第5期321-323,共3页 Cancer Research on Prevention and Treatment
基金 国家自然科学基金 广西区科委基金
关键词 卵巢肿瘤 免疫组织化学 肿瘤转移 CD44V3 CD44V CD44 Immunohistochemistry Ovarian neoplasms Metastasis
  • 相关文献

参考文献1

  • 1Zenro Nihei,Wataru Ichikawa,Kazuyuki Kojima,Sanetaka Togo,Tadahiko Miyanaga,Renzo Hirayama,Yoshio Mishima. The positive relationship between the expression of CD44 variant 6 and prognosis in colorectal cancer[J] 1996,Surgery Today(9):760~761

同被引文献20

  • 1高勇,马宇翔,金宏,李后文.粘附分子CD44v3在胃癌中的表达及其临床意义[J].吉林医药学院学报,2007,28(3):128-132. 被引量:2
  • 2辛榕,郭乔楠,冯俊明.粘附分子CD44、CD44V3、CD44V6及PCNA在人骨肉瘤中的表达及其临床意义[J].第三军医大学学报,2003,25(10):874-876. 被引量:11
  • 3刘子君.骨与关节病理学[M].北京:人民卫生出版社,1994.149-151.
  • 4[7]Wielenga V J, Heider K H, Offerhaus G J, et al. Expression of CD44-variant proteins in human colorectal cancer is related to tumor progression[J]. Cancer Res, 1993,53:4754-4756.
  • 5[8]Kuryu M, Ozaki T, Nishida K, et al. Expression of CD44-variants in osteosarcoma[J]. J Cancer Res Clin Oncol, 1999,125(11):646-652.
  • 6Matsmum Y,Harbury D,Smith J,et al.Non-invasive detection of malignancy by identification of unusual CD44 geneactivity in exfoliated cancer cells[J].BMJ,1994,308:609.
  • 7Christopher J,Amil K.CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma[J].Cancer Res,1995,55(9):1831-1835.
  • 8Rudy W,Hofmann M,Schwartz-Albiez R,et al.The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants:each one individually suffices to confer metastatic behavior[J].Cancer Res,1993,53(6):1262-1268.
  • 9Rail CJ,Rustgi AK.CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma[J].Cancer Res, 1995, 55(9): 1831-1835.
  • 10卿海云,徐艳娟,杨亦萍,曹阳,孙晋虎,庞芳河.舌鳞癌原发灶及其淋巴结转移灶中CD44v3的表达[J].广西医科大学学报,2009,26(3):374-376. 被引量:1

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部